AI
Wednesday, March 13, 2013 5:56:44 PM
GERN CC:
Juan P. Serrate, DVM @JPZaragoza1 dug up who he is and tweeted this link to a seeking alpha article he published.
http://seekingalpha.com/article/249488-just-one-stock-the-biopharma-veteran-facing-a-landmark-stem-cell-trial
I must admit to a passing thought of is it BTH too
. I understand he probably isn't thrilled with management but a lot (almost all) of his questions really didn't find out much of anything. I don't get the big deal about releasing the 10-k and then the CC the next morning. If I were an investor I'd be happy with that gives me time to look at it and ask questions. I don't know what stocks he follows but most Bio's I see actually do the opposite host the call then days later publish the Q/K.
On Geron I started to take a look didn't get too far may still. I wonder if investors would be happier with them going through a 100 million and running their own Phase 2's?
Juan P. Serrate, DVM @JPZaragoza1 dug up who he is and tweeted this link to a seeking alpha article he published.
http://seekingalpha.com/article/249488-just-one-stock-the-biopharma-veteran-facing-a-landmark-stem-cell-trial
I must admit to a passing thought of is it BTH too
. I understand he probably isn't thrilled with management but a lot (almost all) of his questions really didn't find out much of anything. I don't get the big deal about releasing the 10-k and then the CC the next morning. If I were an investor I'd be happy with that gives me time to look at it and ask questions. I don't know what stocks he follows but most Bio's I see actually do the opposite host the call then days later publish the Q/K. On Geron I started to take a look didn't get too far may still. I wonder if investors would be happier with them going through a 100 million and running their own Phase 2's?
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
